We developed a rapid method that uses diphtheria toxin, the flp recognition target sequences, and the GAL4-UAS activation system, to ablate specific neurons in the Drosophila embryo and to examine the consequences in large numbers of embryos at many time points. We used this method to show that, in the absence of the aCC axon, which pioneers the intersegmental nerve in the PNS, the three U follower axons are delayed and make frequent errors. However, the pathway ultimately forms in most segments. We also ablated the axons that pioneer the first longitudinal pathways within the CNS and observed similar results; the formation of longitudinal pathways is delayed and disorganized in 70% of segments, but these tracts ultimately form in 80% of segments. Thus, pioneers facilitate the development of PNS and CNS axon pathways; in their absence, followers are delayed and make numerous errors. However, pioneers are not absolutely required, as these embryos display a remarkable ability to correct for the loss of the pioneering neurons.
Introduction
In 1910, Ross Harrison coined the term "pioneer" based on his examination of the formation of axon pathways in the frog. "The fibers which develop later," he wrote, "follow, in the main, the paths laid down by the pioneers." Since then, studies in a wide variety of organisms from insects to mammals have confirmed Harrison's initial observation that axon pathways are established early in development, when distances are short and the terrain relatively simple (e.g., Bate, 1976; Bate and Grunewald, 1981; Edwards et al., 1981; Goodman et al., 1982; Bentley and Keshishian, 1982; Ho and Goodman, 1982; Raper et al., 1983a; Kuwada, 1986; McConnell et al, 1989; Chitnis and Kuwada, 1990; Wilson et al., 1990) . Axons that arrive much later in development often need these guide fibers to find their way through a more complex and changing environment. For example, transection of a peripheral nerve in the insect Rhodnius prolixis causes subsequent sensory axons that normally follow this nerve to form large whirls and never *These authors contributed equally to this work. tPresent address: Department of Zoology, University of British Columbia, Vancouver, B. C. V6T1Z4, Canada. reach their targets in the CNS (Wigglesworth, 1953) . The ability of the initial axons to guide later growth cones has led to the suggestion that pioneering growth cones might be endowed with special pathfinding abilities. Do subsequent growth cones possess the same pathfinding abilities, or are they different from the pioneers?
Ablation experiments in a variety of organisms thus far have provided a range of conflicting answers to this question. In the grasshopper embryo CNS, the G growth cone turns anteriorly along the P axons in the NP fascicle, a pathway formed by the three descending P and the two ascending A axons. Although the A and P axons normally fasciculate and follow one another, either can pioneer the complete pathway on its own. Furthermore, any one of the P axons will suffice, since when any two of them are ablated the remaining P pioneers the pathway. When the three P axons are ablated, the G growth cone stalls, and neither follows the A axons nor any other longitudinal axons; however, if only one P remains, G will follow it (Raper et al., 1983a (Raper et al., , i983b, 1984 Bastiani et al., 1984) . if one considers all three P axons as the pioneers, then the pioneers are absolutely required for guidance of the G growth cone. However, if one considers P1 as the pioneer, then P2 and P3 clearly have the same ability and can take its place.
Similar results were obtained in the zebrafish, in which elimination of the first of the three primary motoneurons (CAP) or elimination of any two of the three does not prevent the remaining primary motoneuron(s) from extending along the appropriate pathway (Eisen et al., 1989; Pike and Eisen, 1990) . Thus, among certain groups of neurons (e.g., the three P neurons in the grasshopper and the three primary motoneurons in the zebrafish), there does not appear to be a special distinction between the first versus the second or third growth cone's ability to pathfind, whereas a different type of follower axon (e.g., the G growth cone in grasshopper) may in fact have a very different pathfinding ability as compared with the pioneer(s).
These same issues have been examined in a variety of other systems, with a variety of results. In the developing limbs in the grasshopper embryo, a pair of pioneer neurons arise at the tips of limb buds and extend axons toward the CNS (Bate, 1976; Bentley and Keshishian, 1982) . When these neurons are eliminated, follower growth cones are either able (Keshishian and Bentley, 1983) or unable (Klose and Bentley, 1989) to reach the CNS, depending upon the time of axon outgrowth.
In the fish CNS, a particular dorsal spinal cord pathway is pioneered by the axons from a population of transient Rohon-Beard neurons. When these neurons are ablated, the follower growth cones do not extend properly (Kuwada, 1986) . In related experiments, elimination of a brain tract in the zebrafish embryo increases pathfinding errors by follower growth cones, but does not absolutely prevent them from finding their correct pathway (Chitnis and Kuwada, 1991 ) .
Pioneers can also be required for target selection. The transient population of subplate neurons help to pioneer the pathway between the thalamus and cortex (McConnell et al., 1989) . When the subplate neurons are ablated, the axons from a particular thalamic nucleus extend in the white matter under the cortex, but fail to enter their correct target region of cortex (Ghosh et al., 1990) .
In the present paper, we re-explore the role of pioneers in the Drosophila embryo using a novel and rapid ablation method that allows us to ablate specific neurons and examine the consequences in large numbers of embryos at many different time points after ablation. In this way, we have been able to examine both the short-and long-term consequences of ablating these early differentiating neurons.
Toxins such as diphtheria or ricin act by inhibiting protein translation; given sufficient time, a single molecule of diphtheria toxin can completely disrupt cellular function (Yamaizumi et al., 1978) . Diphtheria toxin is composed of two distinct subunits (for review, see Collier, 1975) . By expressing only the A chain subunit (DT-A) within a cell, the ablation can be made cell autonomous. DT-A has been used successfully to ablate various cell types in mice (e.g., Palmiter et al., 1987; Usukura et al., 1994; Lowell et al., 1993) . Stable transformants in flies, however, cannot be easily obtained or maintained without modifying the function of DT-A. Though examples of transformants with wildtype DT-A gene expression do exist (Kalb et al., 1993; Bellen et al., 1992) , this seems to be feasible only if the toxin is expressed in tissues that are not required for viability or fertility.
Because of the difficulties associated with the wild-type DT-A gene, several methods have been developed to regulate toxin expression. Toxin expression can be controlled by inserting a suppressible amber codon in the coding region (Kunes and Steller, 1991) or by generating temperature-and cold-sensitive mutations in the gene (Bellen et al., 1992; Moffat et al., 1992) . These modified toxins can all be used to ablate cells, but 4 or more hours may be required before visible necrotic phenotypes are observed (Moffat et al., 1992) .
These modified toxins have proven useful for studying pupal or adult development, where several days are required for maturation. The embryo, however, develops at a much faster pace. Many of the critical early pathfinding events occur at stage 13, which lasts approximately 1 hr (Campos-Ortega and Hartenstein, 1985) . Any toxin that is used to ablate neurons in the embryo must act within this time frame. Diphtheria toxin can stop protein synthesis in less than 1 hr, depending upon the cell type (Collier, 1975) .
We have developed a novel method called "Blue Death" using diphtheria toxin to study growth cone guidance in the embryo. This has been achieved by maintaining toxin function as close to that of wild type as possible (see Results for design of constructs). We use this new cell ablation method in conjunction with the fushi tarazu (ftz) neurogenic (ftz,g) control element (Hiromi et al., 1985) to study the role of the aCC axon, which pioneers the intersegmental nerve (ISN) pathway. In the absence of the aCC, in the short term, the three U growth cones that normally follow this axon are delayed and make frequent pathfinding errors. In the long term, the ISN pathway eventually does form in 88% of segments. Thus, in this case, the followers, although not as facile in navigating on their own as is the pioneer, are nevertheless ultimately able to form the pathway. We also ablated the axons that pioneer the first longitudinal pathways within the CNS and observed similar results. In the short term, the formation of longitudinal pathways is delayed and disorganized in 70% of segments. However, in the long term, the longitudinal tracts ultimately form in 80% of segments.
Results

Creation of Blue Death Construct and Transformants
To prevent random expression of diphtheria toxin, the coding region was disrupted by insertion of a heterologous gene (Figure 1 ). This insert acts as a "mask" that prevents translation of the toxin so that germline transformants can be maintained. The mask is bounded by tip recognition target (FRT) motifs and can be excised by the yeast site-specific recombinase flp (Golic and Lindquist, 1989) . This is functionally identical to the "tip-out" cassette described by Struhl and Basler (1993) sequence is in frame with that of the toxin. Because the action of flp can be mosaic (Golic and Lindquist, 1989) , the lacZgene was chosen to act as the mask. In the absence of tip, cells containing the masked toxin will express ~-galactosidase. The use of lacZ as the mask for toxin function led us to call this method Blue Death (Figure 1 ).
To maximize the usefulness of this construct, the Blue Death cassette was placed in a UAS~ reporter (R. Kostriken, unpublished data) to take advantage of a large bank of available GAL4 enhancer trap lines (e.g., . The GAL4 system uses a binary activation method to induce expression of a given protein (Brand and Perrimon, 1993; Fischer et al., 1988) . One advantage to using this system is that the expression induced by GAL4 is usually greater than that from the native promoter . By placing the Blue Death construct in a reporter (UAS~-Blue Death), its activation by GAL4 will produce high levels of toxin.
One viable transformant was obtained, and this insert was re-excised using a stable source of transposase (Robertson et al., 1988) to obtain a second, independent insertion. Both inserts were tested by crossing to a GAL4 effector. As expected, progeny embryos displayed 13-galactosidase activity in the pattern induced by the effector, proving that both the UASG and the lacZ sequences in the UASo-Blue Death reporters were intact (data not shown). To show that the FRTand toxin sequences were also functional, a source of flp was introduced by crossing the UASG-Blue Death reporters to a strain containing a heat shock-tip (hs-flp) construct (Golic and Lindquist, 1989) . The hs-flp;UASG-Blue Death recombinants were then tested by crossing to a GAL4 effector. In the absence of heat treatment, embryos from this cross produced [3-galactosidase activity in the expected pattern. When these embryos were heat shocked, no 13-galactosidase activity could be detected, suggesting that the FRTs were intact and could be excised by tip. A minimum time of 45 min at 36°C was required to produce significant flipping activity. When these heat-shocked embryos were stained with various antibodies, severe defects in axon outgrowth were seen. Unfortunately, similar defects were observed with heat-shocked Canton S embryos, indicating that these conditions led to nonspecific axonal defects.
To provide an alternative to heat shock, we decided to inject sense-strand tip RNA into embryos. Embryos were collected from en masse matings between the UASo-Blue Death reporter strain and a GAL4 effector strain, and injected with flp RNA. As a control, embryos were injected with flp antisense RNA.
Combining Blue Death with the ftz.g Control Element
As our initial test of this cell ablation method, we used an effector in which GAL4 is fused to the ftzng control element (Hiromi et al., 1985;  ftz,g-GAL4; D. Van Vactor and C. S.
Goodman, un published data; also used by . The ftz gene is expressed during neurogenesis in approximately 30 of the 200 neurons in each hemisegment (Doe et al., 1988) . However, this pattern is temporally and spatially dynamic, and at early stages, the ftz gene is expressed in only a few neurons. If the/acZ gene is fused directly to the ftzng control element, expression of 13-galactosidase is detected in the first ftzng-expressing neural precursor, MP2, at stage 10. If instead a ftzn~GAL4 effector strain is crossed to a lacZ reporter, ~-galactosidase activity is detected in MP2 at late stage 11. This 1-1.5 hr delay in activation is typical of the GAL4 system (Brand and Perrimon, 1993) . Expression is first detected in MP2 (and its two siblings, dMP2 and vMP2), and is followed soon thereafter by the aCC, its sibling pCC, and the MP1 neurons. The aCC growth cone normally pioneers the ISN at stage 12/1 to 12/0; the three U growth cones follow aCC out the ISN at stage 12/0-early 13. At stage 12/0 to stage early 13, only a small group of neurons strongly express I~-galactosidase as driven by GAL4 in this system, including aCC, pCC, MP1, dMP2, and vMP2; a few other neurons are beginning to express ~-galactosidase at a low level.
As development proceeds, ftz is expressed at higher levels by other neurons as well, ultimately reaching 30 of the 200 neurons per hemisegment by stage late 13. Many of the ftzng-expressing neurons are motoneurons, while the rest are interneu rons whose axons fasciculate in the CNS in the vMP2, MP1, and FN3 longitudinal axon pathways . One feature of the Blue Death system is the ability to identify target cells by assaying for ~-galactosidase expression. As expected, when Blue Death is crossed to ftzn~-GAL4 in the absence of tip, the aCC, pCC, dMP2, vMP2, and MP 1 neurons strongly express 13-galactosidase (data not shown). The identity of these cells was confirmed by using the monoclonal antibody (MAb) 1 D4, which recognizes the fasciclin II protein (G. Helt and C. S. Goodman, unpublished data). At stage 13, MAb 1D4 recognizes the identified ftz-positive neurons MP1, vMP2, dMP2, pCC, and aCC. It also recognizes the U motoneurons, which sit just ventral and medial to aCC, and which do not express ftz. Although we and others have observed a lack of segment-to-segment consistency in the induction associated with using GAL4 (Brand and Perrimon, 1993) , approximately 95% of the expected cells stain with the ~-galactosidase antibody, suggesting a high degree of effectiveness.
Time Course of Toxin Action
Embryos from a cross between the ftzng-GAL4 effector and UAS~-Blue Death reporter were either not injected, injected with flp antisense RNA, or injected with flp sensestrand RNA. As expected, uninjected and antisenseinjected embryos appeared normal when stained with MAb 1D4. When sense-strand flp RNA is injected, however, reduced or no staining of either aCC's or pCC's cell body or axon is observed with MAb 1D4 (Table 1) . As shown in Table 1 , pCC does not stain (and is presumed dead) at stage 12/3 in 54%, at stage 12/2 in 68%, at stage 12/ 1 in 85%, and at stage 12/0 to early 13 in 84% of the segments examined. Thus, inhibition of protein synthesis (and presumably death) is achieved within -60 min of toxin expression and is close to the maximum effectiveness of the GAL4 method (85% versus -95%). Furthermore, expression of the toxin in aCC or pCC, which are adjacent to the U motoneurons, does not affect expression 
Behavior of the U Growth Cones in the Absence of the aCC Axon
The ISN is pioneered by the growth cone of the aCC motoneuron by stage 12/1-12/0. The three U axons follow and fasciculate with aCC's axon by stage 12/0-early 13 ( Figure  2A ). Additional motoneuron axons and growth cones join the nerve as development proceeds.
In antisense flp RNA-injected ftzng-GAL41UASG-Blue Death embryos, the U axons develop normally in 98% of segments (Table 2 ; n = 245). In sense flp RNA-injected embryos, the aCC neuron is ablated in -85% of segments. In these embryos, the U axons are abnormal in 73% of segments at stage early 13 (n = 77; Figure 3 ; shown schematically in Figure 2 ). in 5% of segments, the U axons extend posteriorly and stay within the CNS ( Figure  2B ; Figures 3A, 3D , and 3F). In 27% of segments, the U axons take an abnormal trajectory, extending further posteriorly in the CNS before turning peripherally ( Figure  2C ; Figures 3C and 3E ). in 40% of segments, the U axons extend peripherally, but branch into multiple pathways ( Figure 2D; Figures 3A, 3B, and 3E) . The time at which these phenotypes are most penetrant is stage 12/0-early 13 (Table 2 ), precisely the time at which the U growth cones initially contact and follow the aCC axon.
In several embryos, two of which are shown in Figures  3A and 3D , the mosaic nature of the cell ablation method left one aCC (and its sibling pCC) alive in one hemisegment, whereas in all neighboring hemisegments aCC was ablated. These hemisegments with living aCCs serve as good internal controls, since in each of these hemisegments, the U axons fasciculated with aCC's axon and extended out the ISN with the same timing and trajectory as occurs normally, whereas all neighboring hemisegments with ablated aCC axons showed highly abnormal U axons.
Despite the initial abnormal behavior of the U growth cones at stage 12/0-early 13, as development proceeds the U growth cones correct their initial mistakes (Table 2) .
Significantly fewer defects are detected by stage mid 13, and fewer still by stage late 13. Thus, given the rapid rate of Drosophila embryonic development, this error correction in the U growth cones occurs over a period of about 30 min. By stage 16, only 12% of segments have abnormal ISN trajectories, most of these either displaying a branched peripheral nerve or crossovers from one segment to another in the periphery. (A) In Drosophila, the aCC growth cone is within filopodial grasp of the segment boundary glial cell, and from the outset, turns laterally and pioneers the ISN. The U growth cones arrive at the dorsal surface of the CNS, and then turn and follow aCC's axon. (B-D) In the absence of aCC, the U growth cones typically display a variety of errors and delays at stage 13, including staying within the CNS (B), taking an altered trajectory into the periphery (C), and branching into multiple pathways (D). See Table 2 for further details. (E) In the grasshopper embryo, the aCC growth cone is further away from the segment boundary glial cell that marks the ISN root . The aCC growth cone waits for the U growth cones, which arrive at the dorsal surface of the CNS, turn posteriorly to pioneer the U fascicle, and then turn laterally to pioneer the ISN. The aCC growth cone follows behind. (F) When the U axons are ablated, the aCC growth cone stalls and is unable to pioneer the pathway on its own (du All percentages are of total number of segments examined. NA, not applicable. All percentages are of total number of segments examined.
Formation of Longitudinal Axon Pathways in the Absence of the First Longitudinal Axons
The first two longitudinal axon pathways to form in the CNS of the Drosophila embryo are the vMP2 and MP1 fascicles Fetter et al., unpublished data . The ftzng control element can drive expression of a heterologous gene in many of the neurons whose axons fasciculate in these three pathways .
Because ftzng-GAL41UASo-Blue Death leads to the death of the pCC, vMP2, dMP2, and MP1 neurons at or prior to axonogenesis, the pioneers of both the vMP2 and MP1 pathways can be ablated. To follow the development of these and other longitudinal axon pathways, we stained ftzng-GAL41UASo-Blue Death embryos with MAb 1D4. In control antisense flp RNA-injected ftz,g-GAL41UASG-Blue Death embryos, the MP1 pathway forms normally in i>99% of segments (Table 3) .
In flp sense RNA-injected embryos, the longitudinal axon pathways are either absent or highly abnormal in 70% of segments at stage 14 (Table 3 ). In 43% of segments at stage 14, these pathways are simply missing ( Figures 4A and 4B ). In 27% of segments, these pathways appear abnormal in shape, and the longitudinal pathways in general appear disorganized (Figure 4 ). The effects of ablating the vMP2 and MP1 pathway pioneers decrease but are still apparent at stage 16. In 11% of segments at stage 16, the longitudinal pathways are missing ( Figure  4C ). In another 9% of segments, the longitudinal pathways are present but appear highly disorganized ( Figure 4D ). In other segments, the longitudinal pathways appear partially disorganized. However, as with the ISN, the proportion of segments displaying abnormal phenotypes drops significantly from 70% at stage 14 to 36% at stage 15 to only 20% by stage 16 (Table 3) .
Discussion
We developed a novel, rapid, and efficient cell ablation method and have used it here to study the role of pioneer axons in the formation of both PNS and CNS axon pathways in the Drosophila embryo. We examined the behavior of the U growth cones in the absence of the aCC axon, which pioneers the ISN. The aCC axon appears to facilitate the rapid development of the ISN pathway, but in most cases it is not absolutely essential. In its absence, in the short term, the follower U axons are delayed and make pathfinding errors in 73% of segments (Table 2 ). In the long term, however, they ultimately correct their mistakes and do form the ISN pathway in 88% of segments. We also ablated the axons that pioneer the first longitudinal pathways (pCC, vMP2, dMP2, and MP1; see within the CNS and observed similar short-term versus long-term results. In the short term, the formation of longitudinal pathways is delayed and disorganized in 70% of segments (Table 3) . However, in the long term, the longitudinal tracts ultimately do form in 80% of segments.
Thus, the pioneers appear to play a major role in facilitating the rapid and robust development of PNS and CNS axon pathways. In the absence of the pioneers, followers are delayed and make frequent errors. In the short term, we observed major abnormalities in the formation of the ISN and CNS longitudinal tracts in 73% and 70% of segments, respectively. Given that our ablation method appears to be effective in about 85% of segments (Table 1) , this increases the real short-term percentage of abnormalities to more like 82% of segments in which the cells are actually ablated. However, in spite of this dramatic shortterm effect, in the long term, the pioneers are not absolutely required, in that these embryos display a remarkable ability to correct and compensate for the loss of these early pioneering neurons, a higher degree of plasticity than might have been anticipated.
These results suggest that the first axons, the pioneers, do not necessarily represent a special class of neurons that play an exclusive and necessary role for the formation of the major axon pathways in the CNS and PNS. Rather, the importance of each pioneer depends upon the context of the pathway it establishes in relationship to when and from where the next axons arrive.
It is interesting to compare the results reported here for the formation of the ISN in the Drosophila embryo with previous studies on the formation of the ISN in the grasshopper embryo. In the grasshopper embryo, the aCC growth cone is further away from the segment boundary glial cell that marks the ISN root . The U growth cones arrive at the dorsal surface of the CNS, turn posteriorly to pioneer the U fascicle, and then turn laterally to pioneer the ISN. The aCC growth cone waits for the U axons, and then follows behind them. When the U axons are ablated, the aCC growth cone stalls and is unable to pioneer the pathway on its own (Figures 2E and 2F) (du Lac et al., 1986) .
In contrast, as shown here, one obtains very different results in this divergent insect species. In Drosophila, the aCC growth cone is within filopodial grasp of the segment boundary glial cell, and from the outset turns laterally and pioneers the ISN. The U growth cones arrive at the dorsal surface of the CNS and then turn and follow aCC's axon.
As shown in the present paper, in the absence of aCC, the U growth cones typically make a variety of errors and delays (Figures 2A-2D ), but usually are ultimately able to turn laterally and extend into the periphery to help pioneer a fairly normal ISN pathway.
Thus, the very same pathway (the ISN) and homologous neurons (aCC and the three U axons) provide different results in different species, presumably reflecting evolutionary changes in the pathfinding abilities of particular growth cones. The aCC is the pioneer in Drosophila, whereas the U axons are the pioneers in grasshopper. One consequence is that the ISN forms relatively earlier during the embryogenesis of Drosophila as compared with grasshopper. In Drosophila, the follower U axons can pioneer the pathway in the absence of aCC, although they do not do as robust a job as does aCC. In grasshopper, the follower aCC cannot pioneer the pathway on its own.
These results suggest that changes have occurred during evolution in the ability of these neurons to pioneer the ISN. In one organism (grasshopper), the pioneers (the U axons) of the ISN are absolutely necessary; in the other organism (Drosophila), the pioneer (aCC) of the ISN is not absolutely necessary, but helps facilitate formation of the pathway.
It is unclear why these sorts of evolutionary changes occured in the pathfinding abilities of these homologous neurons. One possibility is that different temporal constraints (particularly the relative early extension of sensory axons toward the CN S in Drosophila as compared with grasshopper) may have helped drive this earlier pioneering function of aCC.
Experimental Procedures
Cloning of Blue Death and Transcription Constructs Standard molecular techniques (Sambrook et al., 1989) were used to create the Blue Death reporter construct and the constructs for in vitro transcription of f/p RNA.
The diphtheria toxin construct was created using the SK402 vector (Kunes and Steller, 1991) as a template. This plasmid contains the A chain of diphtheria toxin in a standard Bluescript vector. A 5' Xbal site upstream of the start o1 translation and a Kpnl site immediately downstream of the initiator methionine were cleaved, and two oligos were inserted. The oligos contain the DT-A ATG and two copies of the minimal FRTsequence (oriented as direct repeats), as well as Notl and Stul restriction endonuclease recognition sequences between the FRTs. These sites were cleaved, and a NotI-Stul fragment containing a/acZ/hsp70 poly(A) chimeric fusion was inserted. When the toxin is activated, the coding region includes an additional 22 amino acids at the 5' end derived from the FRT, whose sequence is MRFEVPIPKFLF-SRKYRN FRAL.
This B/ue Death cassette was excised as a Pstl and Scal (blunted) fragment and placed in a UASG reporter construct (R. Kostriken, unpublished data). The UASG vector contains eight copies of the UAS~ GAL4 binding site, as well as an SV40 polyadenylation sequence.
For the sense and antisense f/p transcription vectors, a 1.4 kb Bglll fragment from DV56 (provided by Paul Sadowski) containing the f/p coding region was inserted in either orientation into the pSP64T transcription vector (Krieg and Melton, 1984) .
In Vitro Transcription
All transcription reactions used Boehringer Mannheim reagents, except for G(5')ppp(5')G (New England Biolabs). The 64T+flp and 64T-flp constructs were linearized by cleavage with Xbal, ethanol precipitated, and resuspended in Tris-EDTA (10 mM Tris [pH 7.0], 1 mM EDTA). Standard SP6 transcription reactions were used to produce RNA. Briefly, each 10 I~1 of reaction contained: 1 i11 of DNA (150 ng of template), 1.5 I11 of ddH20, 1 p_l of G(5')ppp(5')G (10 raM), 1 pJ of 10x buffer (BMB), 2 td of restriction buffer A (2 x ), 2 td of dNTPs (10 mM each), 0.5 Id of RNASin (40 U/p_I), and 1 ~1 of SP6 polymerase (20 U/id). The reaction was incubated at 37°C for 1 hr and stopped with the addition of 34 I~1 of ddH20, 0.7 I~1 of DNase I (RNase-free; 10 U/p_l), 5 I11 of 10 x DNase I buffer (BMB), and 0.5 ~1 of dithiothreitol (1 M). After incubating an additional 15 min at 37°C, the reaction was phenol extracted and ethanol precipitated. The products of six transcription reactions were pooled to produce an average final concentration of 5 i~g/p.I RNA in 10 ~1 of ddH20.
Injection and Embryo Harvesting Protocol
Standard microinjection procedures (Spradling and Rubin, 1982) were followed to inject embryos. To aid in obtaining the initial Blue Death reporter transformants, the construct was coinjected with diphtheria toxin antisense RNA at a concentration of 0.05 p.g/pJ. This helped to inhibit nonspecific translation of the toxin that can occur during injection. To perform the ablation experiments, f/p sense or antisense RNA (5 mg/ml) was injected into embryos at 18°C. The RNA was replaced after 2 hr with fresh solution. Prior to use, RNA was kept frozen on dry ice. Embryos were allowed to develop under Halocarbon 700 oil in a humidified, 18 °C incubator. Upon reaching the desired stage, the embryos were exposed to a gentle stream of water to displace the oil. The water was replaced by fixative (1 x PBS, 3.7% formaldehyde) and incubated at 18°C for 45 min to 1 hr. After removal of the fixative, embryos were washed with PBT (1 x PBS with 0.1% Triton X-100), manually devitellinized, and collected for staining.
The UAS~-B/ue Death reporter was designed to prevent expression of the toxin when inserted into the genome. Less than 5% of all embryos from this stock displayed generic defects (as detected with MAb 1D4), confirming that the construct functioned as predicted. The ftzn~-GAL4 stock also had very few background defects. When the two were crossed together (ftz, , no increase in the percentage of defects occurred. When the injection procedure was tested by injecting antisense flp RNA, the proportion of severely disrupted embryos rose to 15%. This indicates that some additional damage was caused by injection, but not at unacceptable levels. Moreover, these defects are generic and easily distinguishable from toxininduced defects, which are highly specific. Thus, it was easy to eliminate these 15% of highly abnormal embryos from the remaining 85% carrying specific targeted cell ablation defects; these 15% are not counted in Table 1 and Table 2 .
HRP Immunohistochemistry and I~-Galactosidase Activity Assay
HRP immunocytochemistry was carried out as described . The MAb directed against fascielin II (1D4; G. Helt and C, S. Goodman, unpublished data) was used at a dilution of 1:5. ~-Galactosidase activity staining was carried out as described . Embryos were reacted 20 rain to overnight at 37°C. Embryos were staged according to Campos-Ortega and Hartenstein (1985) and Kl~mbt et al. (1991) .
